Related Experiment Video
Updated: May 7, 2026
05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Introduction: Institutional corruption and the pharmaceutical policy.
1Professor at Suffolk University Law School and a Lab Fellow at the Edmond J. Safra Center for Ethics at Harvard University.
Summary
Institutional corruption, including industry funding and lobbying, undermines pharmaceutical policy and medical practice. This systemic issue impacts drug safety, research integrity, and regulatory oversight, affecting patient trust and organizational goals.
Area of Science:
- Health Policy
- Medical Ethics
- Pharmaceutical Science
Background:
- Institutional corruption, defined as systemic practices undermining objectives, compromises pharmaceutical policy and medical practice.
- The pharmaceutical industry's influence through campaign funding and lobbying distorts legislative processes.
- Widespread corruption affects multiple facets of healthcare, including research, drug safety, and regulatory oversight.
Purpose of the Study:
- To investigate the multifaceted nature of institutional corruption within pharmaceutical policy.
- To identify the sources, mechanisms, and targets of corruption in the pharmaceutical sector.
- To analyze the impact of corruption on medical research, practice, and regulatory bodies.
Main Methods:
- A symposium featuring 16 articles examining different aspects of pharmaceutical policy corruption.
- Analysis of systemic practices, including legal but integrity-undermining actions.
- Examination of industry funding, lobbying, and their influence on legislation.
Main Results:
- Pharmaceutical industry funding significantly skews the legislative process for pharmaceutical policy.
- Corruption has compromised medical research, knowledge production, clinical practice, and drug safety.
- Oversight by the Food and Drug Administration (FDA) and the trustworthiness of patient advocacy groups are negatively impacted.
Conclusions:
- Institutional corruption poses a significant threat to the integrity of pharmaceutical policy and medical practice.
- Addressing corruption is crucial for restoring trust in medical research, drug safety, and regulatory oversight.
- The pharmaceutical industry's influence undermines its own stated purposes and public health goals.
Related Concept Videos
01:03Drug Control Governance: Regulatory Bodies and Their Impact
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...
01:25Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
01:28Drug Products: Biologics, Biosimilars and Interchangeables
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
01:02Prescription, Nonprescription and Orphan Drugs
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
01:19Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...